Shopping Cart
- Remove All
- Your shopping cart is currently empty
ART0380 is a potent, selective, orally available, ATP-competitive ATR kinase inhibitor (IC50=51.7 nM) with antitumor activity for the study of ataxia telangiectasia mutated (ATM) cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $64 | In Stock | |
5 mg | $156 | In Stock | |
10 mg | $222 | In Stock | |
25 mg | $396 | In Stock | |
50 mg | $562 | In Stock | |
100 mg | $787 | In Stock | |
200 mg | $1,070 | In Stock | |
1 mL x 10 mM (in DMSO) | $169 | In Stock |
Description | ART0380 is a potent, selective, orally available, ATP-competitive ATR kinase inhibitor (IC50=51.7 nM) with antitumor activity for the study of ataxia telangiectasia mutated (ATM) cancer. |
In vivo | ART0380 is a potent and selective ATR inhibitor with a compelling in vitro and in vivo pharmacological profile and is currently in Phase 2 clinical studies in patients with advanced or metastatic solid tumors as monotherapy and in combination with DNA damaging agents (NCT04657068 and NCT05798611). ART0380 has a favorable human PK profile suitable for both intermittent and continuous once-daily (QD) dosing, characterized by dose-proportional increases in exposure and low variability. [2] |
Alias | IACS-030380, IACS030380, ART 0380 |
Molecular Weight | 388.49 |
Formula | C18H24N6O2S |
Cas No. | 2267316-76-5 |
Smiles | C[C@H]1N(C2=NC(=NC(N=S(C)(=O)C3CC3)=C2)C=4C=C(N)N=CC4)CCOC1 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.